Myoclonic epilepsy of Lafora
Lafora disease

Contact us
 
Return to database


We were unfortunately unable to download the information for this disease from OMIM.



Prevalence of clinical parameters (%)







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Seizures nervous 94 % 15781812 2013-04-09
Mental retardation nervous 82 % 15781812 2013-04-09
Gait disturbances nervous 47 % 15781812 2013-04-09
Hepatopathy digestive 6 % 15781812 2013-04-09



List of references:


Lafora disease due to EPM2B mutations: a clinical and genetic study.
C Gómez-Abad, P Gómez-Garre, E Gutiérrez-Delicado, S Saygi, R Michelucci, C A Tassinari, S Rodríguez de Córdoba, J M Serratosa,

To study EPM2B gene mutations and genotype-phenotype correlations in patients with Lafora disease.

Neurology - Mar 2005